Drug Profile
Ovarian cancer vaccine - Biomira
Alternative Names: TFalphaKLHLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Biomira
- Class Cancer vaccines; Conjugate vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ovarian cancer
Most Recent Events
- 11 Aug 1999 New profile, split from generic Ovarian cancer vaccine profile
- 11 Aug 1999 No-Development-Reported for Ovarian cancer in Canada (Unknown route)